Norris Medicines Ltd Stock Price Today (NSE: NORRIS)
Fundamental Score
Norris Medicines Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Norris Medicines Ltd share price today is ₹14.50, up +9.68% on NSE/BSE as of 22 June 2026. Norris Medicines Ltd (NORRIS) is a Small-cap company in the Trading & Distributors sector with a market capitalisation of ₹14.52 (Cr). The 52-week high for NORRIS share price is ₹19.33 and the 52-week low is ₹12.00.
Norris Medicines Ltd Share Price Chart — NSE/BSE Historical Performance
Norris Medicines Ltd share price chart: -11.00% return over the past month. 52-week high ₹19.33, 52-week low ₹12.00.
Norris Medicines Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹13.22 | ₹14.50 | ₹13.22 | ₹14.50 | 1.20K (Cr) | |
| ₹13.31 | ₹13.75 | ₹13.22 | ₹13.22 | 261.00 (Cr) | |
| ₹13.40 | ₹14.00 | ₹13.00 | ₹13.25 | 1.87K (Cr) | |
| ₹13.28 | ₹14.96 | ₹13.28 | ₹13.35 | 3.16K (Cr) | |
| ₹13.00 | ₹14.19 | ₹13.00 | ₹14.19 | 1.33K (Cr) | |
| ₹13.99 | ₹13.99 | ₹13.00 | ₹13.00 | 1.28K (Cr) | |
| ₹13.50 | ₹14.30 | ₹13.00 | ₹13.00 | 1.96K (Cr) | |
| ₹13.10 | ₹13.50 | ₹12.75 | ₹13.00 | 398.00 (Cr) | |
| ₹13.10 | ₹13.10 | ₹12.76 | ₹12.76 | 203.00 (Cr) | |
| ₹13.50 | ₹13.50 | ₹12.77 | ₹13.05 | 439.00 (Cr) |
Norris Medicines Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹13.31 | ₹14.50 | ₹13.22 | ₹14.50 | +8.94% | |
| ₹14.75 | ₹14.97 | ₹12.75 | ₹13.25 | -10.17% | |
| ₹13.62 | ₹15.67 | ₹12.76 | ₹14.25 | +4.63% | |
| ₹15.27 | ₹15.27 | ₹12.00 | ₹13.35 | -12.57% | |
| ₹14.00 | ₹15.50 | ₹12.50 | ₹15.23 | +8.79% | |
| ₹14.60 | ₹17.00 | ₹12.50 | ₹14.20 | -2.74% | |
| ₹15.75 | ₹19.25 | ₹14.00 | ₹15.95 | +1.27% | |
| ₹16.12 | ₹17.00 | ₹15.00 | ₹15.00 | -6.95% | |
| ₹16.50 | ₹17.50 | ₹15.00 | ₹15.80 | -4.24% | |
| ₹15.76 | ₹17.95 | ₹15.75 | ₹16.06 | +1.90% | |
| ₹17.25 | ₹18.75 | ₹15.50 | ₹16.01 | -7.19% | |
| ₹18.95 | ₹18.95 | ₹15.51 | ₹16.85 | -11.08% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Norris Medicines Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Norris Medicines Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NORRIS across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Revenue Growth (57.48%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Suboptimal ROCE (-10.13%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-3.20%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-100.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Growth History (-5.78% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-2.02x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 0.07%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Norris Medicines Ltd vs Trading & Distributors Peers
Peer Comparison - Trading & Distributors
Compare Norris Medicines Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Norris Medicines LtdNorris Medicine...Selected✓ NORRIS • 524414 | 14/100 | ₹14.50₹15 | ₹14.52₹14.52 | — — | — — | -10.13%Poor -10.13% Poor | — — | 9.35%Good 9.35% Good | -5.78%Poor -5.78% Poor | 0.00% |
Redington LtdRedington Ltd... REDINGTON • 532805 | 58.5/100 | ₹222.80₹223 | ₹22049.92₹22049.92 | 16.14Average 16.1 Average | 14.39%Average 14.39% Average | 18.90%Good 18.90% Good | 0.29Excellent 0.3 Excellent | 17.72%Excellent 17.72% Excellent | 14.06%Good 14.06% Good | 2.41% |
MMTC LtdMMTC Ltd... MMTC • 513377 | 32.1/100 | ₹65.99₹66 | ₹8949.04₹8949.04 | 127.30Average 127.3 Average | 5.87%Poor 5.87% Poor | 7.70%Poor 7.70% Poor | 0.02Excellent 0.0 Excellent | 19.08%Excellent 19.08% Excellent | -86.52%Poor -86.52% Poor | 0.00% |
MSTC LtdMSTC Ltd... MSTCLTD • 542597 | 63.7/100 | ₹438.75₹439 | ₹3458.41₹3458.41 | 15.65Average 15.7 Average | 28.37%Excellent 28.37% Excellent | 29.26%Excellent 29.26% Excellent | 0.17Excellent 0.2 Excellent | 15.18%Excellent 15.18% Excellent | -24.06%Poor -24.06% Poor | 8.24% |
BN Holdings LtdBN Holdings Ltd... BNHOLDINGS • 526125 | 24.7/100 | ₹404.70₹405 | ₹3333.57₹3333.57 | 49.50Average 49.5 Average | 26.05%Excellent 26.05% Excellent | 27.44%Excellent 27.44% Excellent | 0.20Excellent 0.2 Excellent | — — | — — | 0.00% |
Vintage Coffee And Beverages IncVintage Coffee ... VINCOFE • 538920 | 11.1/100 | ₹154.05₹154 | ₹2132.64₹2132.64 | 35.45Average 35.5 Average | 17.05%Good 17.05% Good | 15.42%Good 15.42% Good | 0.17Excellent 0.2 Excellent | — — | — — | 0.06% |
TCC Concept LtdTCC Concept Ltd... TCC • 512038 | 34.8/100 | ₹379.00₹379 | ₹1813.06₹1813.06 | 38.36Average 38.4 Average | 9.28%Poor 9.28% Poor | 11.83%Average 11.83% Average | 0.05Excellent 0.1 Excellent | — — | — — | 0.00% |
Euro Asia Exports LtdEuro Asia Expor... EUROASIA • 530929 | 66.6/100 | ₹637.25₹637 | ₹1297.46₹1297.46 | 518.98Average 519.0 Average | 87.02%Excellent 87.02% Excellent | 82.72%Excellent 82.72% Excellent | 0.00Excellent 0.0 Excellent | 158.76%Excellent 158.76% Excellent | 66.77%Excellent 66.77% Excellent | 0.00% |
41.9/100 | ₹18.76₹19 | ₹1111.34₹1111.34 | 402.66Average 402.7 Average | 1.24%Poor 1.24% Poor | 2.46%Poor 2.46% Poor | 0.06Excellent 0.1 Excellent | 61.76%Excellent 61.76% Excellent | 35.83%Excellent 35.83% Excellent | 0.00% | |
Yamuna Syndicate LtdYamuna Syndicat... YSL • 540980 | 32.3/100 | ₹30300.00₹30300 | ₹1021.99₹1021.99 | 11.71Average 11.7 Average | 9.31%Poor 9.31% Poor | 9.39%Poor 9.39% Poor | 0.00Excellent 0.0 Excellent | 10.82%Good 10.82% Good | 4.86%Average 4.86% Average | 1.50% |
Oswal Agro Mills LtdOswal Agro Mill... OSWALAGRO • 500317 | 62.3/100 | ₹45.83₹46 | ₹811.32₹811.32 | 6.43Average 6.4 Average | 12.62%Average 12.62% Average | 16.29%Good 16.29% Good | 0.00Excellent 0.0 Excellent | 28.35%Excellent 28.35% Excellent | 61.75%Excellent 61.75% Excellent | 0.00% |
Top Trading & Distributors Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Redington Ltd share price22049.92 Cr
- MMTC Ltd share price8949.04 Cr
- MSTC Ltd share price3458.41 Cr
- BN Holdings Ltd share price3333.57 Cr
- Vintage Coffee And Beverages Inc share price2132.64 Cr
Norris Medicines Ltd Quarterly Performance
Latest quarterly metrics for NORRIS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
57.48%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-100.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-5.78%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
9.35%
Compounded annual net profit growth over 5 years
Norris Medicines Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NORRIS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Norris Medicines Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Norris Medicines Ltd (NORRIS) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Norris Medicines Ltd
About NORRIS (Norris Medicines Ltd)
Norris Medicines Ltd is a dynamic trading and distribution company specializing in the procurement and delivery of a broad spectrum of pharmaceutical products and healthcare soluti...ons. Operating within the complex Indian pharmaceutical landscape, Norris acts as a critical link connecting manufacturers with a vast network of retailers, hospitals, and healthcare providers. The company meticulously manages its supply chain, ensuring timely and efficient distribution of essential medicines and healthcare products across diverse geographical regions. Norris is dedicated to maintaining the highest standards of quality and compliance, meticulously adhering to regulatory guidelines and industry best practices to safeguard the integrity of the products they handle. Norris Medicines Ltd distinguishes itself through its comprehensive portfolio of traded and distributed products, catering to a wide range of therapeutic areas. These include, but are not limited to, essential medications for common ailments, specialized treatments for chronic conditions, and various healthcare supplies designed to enhance patient well-being. Beyond simply moving products, Norris focuses on building strong relationships with both its suppliers and its customers, fostering trust and collaboration. They actively monitor market trends and patient needs, enabling them to adapt their offerings and ensure that healthcare professionals have access to the medications and tools they require to provide optimal care. Norris Medicines Ltd is committed to facilitating access to quality healthcare solutions throughout India. By strategically managing logistics, maintaining stringent quality control measures, and fostering collaborative partnerships, the company plays a vital role in the healthcare ecosystem. With a focus on reliability and efficiency, Norris strives to be a trusted partner for both manufacturers and healthcare providers, contributing to improved patient outcomes and a healthier community. They are driven by a commitment to ethical business practices and a dedication to supporting the evolving needs of the Indian healthcare sector.
Company Details
Key Leadership
Latest News
NORRIS Share Price: Frequently Asked Questions
What is the current share price of Norris Medicines Ltd?
Norris Medicines Ltd (NORRIS) trades at ₹14.50 on NSE and BSE. Market cap ₹14.52 (Cr). Educational data only.
What is the P/E ratio of Norris Medicines Ltd?
Norris Medicines Ltd has a P/E of N/Ax vs industry average 35.45x.
What is the Bull Run score for Norris Medicines Ltd?
Norris Medicines Ltd has a Bull Run score of 14/100 based on 25+ financial parameters.
Does Norris Medicines Ltd pay dividends?
Norris Medicines Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Norris Medicines Ltd?
Norris Medicines Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Norris Medicines Ltd?
Norris Medicines Ltd has debt-to-equity of N/A.
Is Norris Medicines Ltd a good investment?
Bull Run gives Norris Medicines Ltd a score of 14/100. This is not investment advice — consult a SEBI-registered advisor.